Literature DB >> 9175935

Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response.

R Munro1, H Capell.   

Abstract

OBJECTIVE: To ascertain the prevalence of low body mass in a rheumatoid arthritis (RA) population and to explore a possible relation with the acute phase response.
METHODS: 97 patients who fulfilled the American College of Rheumatology (ACR) criteria for RA were recruited. Change in weight from initial presentation was noted. Body mass index (BMI), upper arm fat and muscle areas were recorded together with fat free mass calculated from the waist measurement. Blood samples were taken for erythrocyte sedimentation rate (ESR), C reactive protein (CRP), and serum albumin.
RESULTS: 13% of the RA group fell into the lowest 5th centile for BMI for the general population. The loss of body mass was greater for lean tissue than fat, with over 50% of the RA group falling into the lowest 10th centile of a reference population for the upper arm muscle area. Female patients who lost greater than 15% of their initial weight had higher health assessment questionnaire (HAQ) results than the rest of the group (p = 0.020). In female patients there was a significant correlation between reduced fat free mass and the acute phase response (ESR p = 0.016 and CRP p = 0.003)
CONCLUSIONS: There is an increased prevalence of low body mass, greatest for lean tissue, in the RA population. In the female group there was an inverse relation between the acute phase response and fat free mass. Female patients with RA who lose a significant amount of weight are more disabled as assessed by HAQ.

Entities:  

Mesh:

Year:  1997        PMID: 9175935      PMCID: PMC1752373          DOI: 10.1136/ard.56.5.326

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

Review 1.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

2.  Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis.

Authors:  Rachel A Brown; Domenico Spina; Sayqa Butt; Gregory D Summers
Journal:  Clin Rheumatol       Date:  2011-10-19       Impact factor: 2.980

3.  Predictors of longterm changes in body mass index in rheumatoid arthritis.

Authors:  Joshua F Baker; Grant W Cannon; Said Ibrahim; Candace Haroldsen; Liron Caplan; Ted R Mikuls
Journal:  J Rheumatol       Date:  2015-04-01       Impact factor: 4.666

4.  Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis.

Authors:  Kazutaka Masamoto; Bungo Otsuki; Shunsuke Fujibayashi; Koichiro Shima; Hiromu Ito; Moritoshi Furu; Motomu Hashimoto; Masao Tanaka; Stephen Lyman; Hiroyuki Yoshitomi; Shimei Tanida; Tsuneyo Mimori; Shuichi Matsuda
Journal:  Eur Spine J       Date:  2017-11-28       Impact factor: 3.134

5.  Should we look for osteoporosis in patients with rheumatoid arthritis?

Authors:  W F Lems; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

6.  Dose-Response Relationship Between Neuromuscular Electrical Stimulation and Muscle Function in People With Rheumatoid Arthritis.

Authors:  Gustavo J Almeida; Samannaaz S Khoja; Sara R Piva
Journal:  Phys Ther       Date:  2019-09-01

7.  Sarcopenia in women with rheumatoid arthritis.

Authors:  Sevil Ceyhan Doğan; Sami Hizmetli; Emrullah Hayta; Ece Kaptanoğlu; Taner Erselcan; Emel Güler
Journal:  Eur J Rheumatol       Date:  2015-03-31

8.  Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.

Authors:  P Sarzi-Puttini; F Atzeni; J Schölmerich; M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

9.  Association between Disability and Psychological Factors and Dose of Neuromuscular Electrical Stimulation in Subjects with Rheumatoid Arthritis.

Authors:  Sara R Piva; Stephanie Lasinski; Gustavo Jm Almeida; G Kelley Fitzgerald; Anthony Delitto
Journal:  Physiother Pract Res       Date:  2013-01-01

Review 10.  The influence of ageing on the development and management of rheumatoid arthritis.

Authors:  Annemieke M H Boots; Andrea B Maier; Piet Stinissen; Pierre Masson; Rik J Lories; Filip De Keyser
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.